⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIIB News
Biogen Inc. Common Stock
Sorcero Introduces Field Medical Excellence & Insights and Congress Intelligence Solutions to Accelerate Evidence-based Medical Affairs Strategies
prnewswire.com
AMGN
BIIB
ARGX
Saphnelo Surpasses Benlysta in CLE as Physicians Expand Use of Biologics Ahead of Key 2027 Catalysts
globenewswire.com
AZN
GSK
BIIB
GLP-1 Receptor Agonist Market to Hit USD 78.4 Billion by 2032, Growing at a CAGR of 3.66% with Rising Demand for Metabolic Disease Therapies | MarkNtel Advisors
prnewswire.com
LLY
BIIB
Recludix Pharma Promotes Executive Leaders Following Recent Corporate Accomplishments
globenewswire.com
AMGN
BIIB
MRK
SNY
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Avantor, Inc. (AVTR), Baxter International Inc. (BAX), Biogen Inc. (BIIB), and CarMax, Inc. (KMX)
globenewswire.com
AVTR
BAX
BIIB
KMX
Form 8-K
sec.gov
BIIB
Biogen Presents Additional Salanersen Data Showing New Motor Milestones Achieved in Children with SMA Previously Treated with Gene Therapy
globenewswire.com
BIIB
Latest data on long-term, real-world treatment with lecanemab will be presented at the AD/PD™ 2026 congress USA - English USA - English
prnewswire.com
BIIB
Latest data on long-term, real-world treatment with lecanemab will be presented at the AD/PD™ 2026 congress USA - English USA - English
prnewswire.com
BIIB
Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD™ 2026 Annual Meeting
prnewswire.com
BIIB